Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 127 articles:
HTML format
Text format



Single Articles


    October 2017
  1. LI X, Yang H, Ke J, Liu B, et al
    Smad4 re-expression increases the sensitivity to parthenolide in colorectal cancer.
    Oncol Rep. 2017;38:2317-2324.
    PubMed     Text format     Abstract available


  2. WU S, Wu F, Jiang Z
    Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer.
    Oncol Rep. 2017;38:2043-2050.
    PubMed     Text format     Abstract available


    September 2017
  3. LI Y, Wang C, Li D, Deng P, et al
    1H-NMR-based metabolic profiling of a colorectal cancer CT-26 lung metastasis model in mice.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5954.
    PubMed     Text format     Abstract available


  4. FEI R, Zhang Y, Wang S, Xiang T, et al
    alpha7 nicotinic acetylcholine receptor in tumor-associated macrophages inhibits colorectal cancer metastasis through the JAK2/STAT3 signaling pathway.
    Oncol Rep. 2017 Sep 4. doi: 10.3892/or.2017.5935.
    PubMed     Text format     Abstract available


    August 2017
  5. TANG X, Zha L, Li H, Liao G, et al
    Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/beta-catenin signaling pathway.
    Oncol Rep. 2017 Aug 25. doi: 10.3892/or.2017.5923.
    PubMed     Text format     Abstract available


  6. SUI H, Duan P, Guo P, Hao L, et al
    Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer.
    Oncol Rep. 2017 Aug 23. doi: 10.3892/or.2017.5917.
    PubMed     Text format     Abstract available


  7. CHEN LD, Liu ZH, Zhang LF, Yao JN, et al
    Sanggenon C induces apoptosis of colon cancer cells via inhibition of NO production, iNOS expression and ROS activation of the mitochondrial pathway.
    Oncol Rep. 2017 Aug 22. doi: 10.3892/or.2017.5912.
    PubMed     Text format     Abstract available


  8. WU W, Chen J, Wu J, Lin J, et al
    Knockdown of tripartite motif-59 inhibits the malignant processes in human colorectal cancer cells.
    Oncol Rep. 2017 Aug 10. doi: 10.3892/or.2017.5896.
    PubMed     Text format     Abstract available


  9. LIN J, Feng J, Yang H, Yan Z, et al
    Scutellaria barbata D. Don inhibits 5-fluorouracil resistance in colorectal cancer by regulating PI3K/AKT pathway.
    Oncol Rep. 2017 Aug 9. doi: 10.3892/or.2017.5892.
    PubMed     Text format     Abstract available


  10. WANG M, He SF, Liu LL, Sun XX, et al
    Potential role of ZEB1 as a DNA repair regulator in colorectal cancer cells revealed by cancer-associated promoter profiling.
    Oncol Rep. 2017 Aug 8. doi: 10.3892/or.2017.5888.
    PubMed     Text format     Abstract available


    July 2017
  11. LI S, Yang G, Zhu X, Cheng L, et al
    Combination of rapamycin and garlic-derived S-allylmercaptocysteine induces colon cancer cell apoptosis and suppresses tumor growth in xenograft nude mice through autophagy/p62/Nrf2 pathway.
    Oncol Rep. 2017 Jul 24. doi: 10.3892/or.2017.5849.
    PubMed     Text format     Abstract available


  12. YAN W, Bai Z, Wang J, Li X, et al
    ANP32A modulates cell growth by regulating p38 and Akt activity in colorectal cancer.
    Oncol Rep. 2017 Jul 21. doi: 10.3892/or.2017.5845.
    PubMed     Text format     Abstract available


  13. HUANG W, Tian Y, Dong S, Cha Y, et al
    The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5837.
    PubMed     Text format     Abstract available


  14. HWANG NL, Kang YJ, Sung B, Hwang SY, et al
    MHY451 induces cell cycle arrest and apoptosis by ROS generation in HCT116 human colorectal cancer cells.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5836.
    PubMed     Text format     Abstract available


  15. SUN J, Xu K, Qiu Y, Gao H, et al
    Bufalin reverses acquired drug resistance by inhibiting stemness in colorectal cancer cells.
    Oncol Rep. 2017 Jul 17. doi: 10.3892/or.2017.5826.
    PubMed     Text format     Abstract available


  16. LEE MS, Kim MS, Yoo JK, Lee JY, et al
    Enhanced anticancer effects of a mixture of low-dose mushrooms and Panax ginseng root extracts in human colorectal cancer cells.
    Oncol Rep. 2017 Jul 7. doi: 10.3892/or.2017.5796.
    PubMed     Text format     Abstract available


  17. WANG HG, Cao B, Zhang LX, Song N, et al
    KLF2 inhibits cell growth via regulating HIF-1alpha/Notch-1 signal pathway in human colorectal cancer HCT116 cells.
    Oncol Rep. 2017;38:584-590.
    PubMed     Text format     Abstract available


    June 2017
  18. MA Y, Wu L, Liu X, Xu Y, et al
    KLF4 inhibits colorectal cancer cell proliferation dependent on NDRG2 signaling.
    Oncol Rep. 2017 Jun 21. doi: 10.3892/or.2017.5736.
    PubMed     Text format     Abstract available


  19. ISHIDA T, Ishii Y, Tsuruta M, Okabayashi K, et al
    Cetuximab promotes SN38 sensitivity via suppression of heat shock protein 27 in colorectal cancer cells with wild-type RAS.
    Oncol Rep. 2017 Jun 21. doi: 10.3892/or.2017.5734.
    PubMed     Text format     Abstract available


  20. ALTOBELLI E, Latella G, Morroni M, Licini C, et al
    Low HtrA1 expression in patients with longstanding ulcerative colitis and colorectal cancer.
    Oncol Rep. 2017 Jun 6. doi: 10.3892/or.2017.5700.
    PubMed     Text format     Abstract available


  21. DE ALMEIDA CV, Zamame JA, Romagnoli GG, Rodrigues CP, et al
    Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5692.
    PubMed     Text format     Abstract available


  22. ZHANG X, Sukamporn P, Zhang S, Min KW, et al
    3,3'-diindolylmethane downregulates cyclin D1 through triggering endoplasmic reticulum stress in colorectal cancer cells.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5693.
    PubMed     Text format     Abstract available


  23. KOWALCZYK AE, Krazinski BE, Godlewski J, Kiewisz J, et al
    Expression of the EP300, TP53 and BAX genes in colorectal cancer: Correlations with clinicopathological parameters and survival.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5687.
    PubMed     Text format     Abstract available


    May 2017
  24. CUYAS E, Queralt B, Martin-Castillo B, Bosch-Barrera J, et al
    EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells.
    Oncol Rep. 2017 May 30. doi: 10.3892/or.2017.5682.
    PubMed     Text format     Abstract available


  25. WANG W, Deng J, Wang Q, Yao Q, et al
    Synergistic role of Cul1 and c-Myc: Prognostic and predictive biomarkers in colorectal cancer.
    Oncol Rep. 2017 May 25. doi: 10.3892/or.2017.5671.
    PubMed     Text format     Abstract available


  26. CHEN LG, Xia YJ, Cui Y
    Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.
    Oncol Rep. 2017 May 24. doi: 10.3892/or.2017.5666.
    PubMed     Text format     Abstract available


  27. ZENG YH, Zhou LY, Chen QZ, Li Y, et al
    Resveratrol inactivates PI3K/Akt signaling through upregulating BMP7 in human colon cancer cells.
    Oncol Rep. 2017 May 23. doi: 10.3892/or.2017.5662.
    PubMed     Text format     Abstract available


  28. SUN Y, Ji B, Feng Y, Zhang Y, et al
    TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
    Oncol Rep. 2017 May 22. doi: 10.3892/or.2017.5654.
    PubMed     Text format     Abstract available


  29. ZHANG L, Fang Y, Feng JY, Cai QY, et al
    Chloroform fraction of Scutellaria barbata D. Don inhibits the growth of colorectal cancer cells by activating miR34a.
    Oncol Rep. 2017 May 4. doi: 10.3892/or.2017.5625.
    PubMed     Text format     Abstract available


  30. YE M, He Y, Lin H, Yang S, et al
    High expression of atonal homolog 8 predicts a poor clinical outcome in patients with colorectal cancer and contributes to tumor progression.
    Oncol Rep. 2017;37:2955-2963.
    PubMed     Text format     Abstract available


  31. ARRIAGA JM, Bravo AI, Mordoh J, Bianchini M, et al
    Metallothionein 1G promotes the differentiation of HT-29 human colorectal cancer cells.
    Oncol Rep. 2017;37:2633-2651.
    PubMed     Text format     Abstract available


    April 2017
  32. WEN L, Li Y, Jiang Z, Zhang Y, et al
    miR-944 inhibits cell migration and invasion by targeting MACC1 in colorectal cancer.
    Oncol Rep. 2017 Apr 28. doi: 10.3892/or.2017.5611.
    PubMed     Text format     Abstract available


  33. WANG Y, Lu Z, Wang N, Zhang M, et al
    MicroRNA-1299 is a negative regulator of STAT3 in colon cancer.
    Oncol Rep. 2017 Apr 26. doi: 10.3892/or.2017.5605.
    PubMed     Text format     Abstract available


  34. LIU W, Qian K, Wei X, Deng H, et al
    miR27a promotes proliferation, migration, and invasion of colorectal cancer by targeting FAM172A and acts as a diagnostic and prognostic biomarker.
    Oncol Rep. 2017 Apr 20. doi: 10.3892/or.2017.5592.
    PubMed     Text format     Abstract available


  35. ZHANG Y, Fang F, Fan K, Zhang Y, et al
    Effective cytotoxic activity of OSW-1 on colon cancer by inducing apoptosis in vitro and in vivo.
    Oncol Rep. 2017 Apr 19. doi: 10.3892/or.2017.5582.
    PubMed     Text format     Abstract available


  36. ABDULLA MH, Valli-Mohammed MA, Al-Khayal K, Al Shkieh A, et al
    Cathepsin B expression in colorectal cancer in a Middle East population: Potential value as a tumor biomarker for late disease stages.
    Oncol Rep. 2017 Apr 18. doi: 10.3892/or.2017.5576.
    PubMed     Text format     Abstract available


  37. WANG H, Li S, Luo X, Song Z, et al
    Knockdown of PARP6 or survivin promotes cell apoptosis and inhibits cell invasion of colorectal adenocarcinoma cells.
    Oncol Rep. 2017;37:2245-2251.
    PubMed     Text format     Abstract available


  38. LUPUT L, Licarete E, Sesarman A, Patras L, et al
    Tumor-associated macrophages favor C26 murine colon carcinoma cell proliferation in an oxidative stress-dependent manner.
    Oncol Rep. 2017;37:2472-2480.
    PubMed     Text format     Abstract available


  39. KAKIZAWA N, Suzuki K, Fukui T, Takayama Y, et al
    Clinical and molecular assessment of regorafenib monotherapy.
    Oncol Rep. 2017;37:2506-2512.
    PubMed     Text format     Abstract available


  40. WANG YP, Guo PT, Zhu Z, Zhang H, et al
    Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway in human colorectal adenocarcinoma.
    Oncol Rep. 2017;37:1961-1970.
    PubMed     Text format     Abstract available


    March 2017
  41. AL BANDAR MH, Kim NK
    Current status and future perspectives on treatment of liver metastasis in colorectal cancer (Review).
    Oncol Rep. 2017 Mar 27. doi: 10.3892/or.2017.5531.
    PubMed     Text format     Abstract available


  42. KAWASAKI H, Saotome T, Usui T, Ohama T, et al
    Regulation of intestinal myofibroblasts by KRas-mutated colorectal cancer cells through heparin-binding epidermal growth factor-like growth factor.
    Oncol Rep. 2017 Mar 22. doi: 10.3892/or.2017.5520.
    PubMed     Text format     Abstract available


  43. GUO F, Chen JJ, Tang WJ
    CIRH1A augments the proliferation of RKO colorectal cancer cells.
    Oncol Rep. 2017 Mar 8. doi: 10.3892/or.2017.5497.
    PubMed     Text format     Abstract available


  44. YUAN Z, Shi X, Qiu Y, Jia T, et al
    Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin.
    Oncol Rep. 2017;37:1815-1825.
    PubMed     Text format     Abstract available


  45. LIN XY, Chen SZ
    Calpain inhibitors ameliorate muscle wasting in a cachectic mouse model bearing CT26 colorectal adenocarcinoma.
    Oncol Rep. 2017;37:1601-1610.
    PubMed     Text format     Abstract available


  46. HUANG C, Liu H, Gong XL, Wu LY, et al
    Effect of evodiamine and berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-beta1.
    Oncol Rep. 2017;37:1637-1645.
    PubMed     Text format     Abstract available


  47. FU Y, Liu Y, Wang J, Li C, et al
    Calcium release induced by 2-pyridinecarboxaldehyde thiosemicarbazone and its copper complex contributes to tumor cell death.
    Oncol Rep. 2017;37:1662-1670.
    PubMed     Text format     Abstract available


    February 2017
  48. YUAN X, Sun X, Shi X, Wang H, et al
    USP39 promotes colorectal cancer growth and metastasis through the Wnt/beta-catenin pathway.
    Oncol Rep. 2017 Feb 15. doi: 10.3892/or.2017.5454.
    PubMed     Text format     Abstract available


  49. DAI X, Liu J, Nian Y, Qiu MH, et al
    A novel cycloartane triterpenoid from Cimicifuga induces apoptotic and autophagic cell death in human colon cancer HT-29 cells.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5444.
    PubMed     Text format     Abstract available


  50. SHEN T, Yang Z, Cheng X, Xiao Y, et al
    CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-kappaB signaling pathway.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5453.
    PubMed     Text format     Abstract available


  51. CHAI Y, Xu J, Yan B
    The anti-metastatic effect of baicalein on colorectal cancer.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5437.
    PubMed     Text format     Abstract available


  52. SHOJI H, Motegi M, Takakusagi Y, Asao T, et al
    Chemoradiotherapy and concurrent radiofrequency thermal therapy to treat primary rectal cancer and prediction of treatment responses.
    Oncol Rep. 2017;37:695-704.
    PubMed     Text format     Abstract available


  53. WANG X, Liu C, Wang J, Fan Y, et al
    Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-beta1/Smad signaling pathway.
    Oncol Rep. 2017;37:747-753.
    PubMed     Text format     Abstract available


    January 2017
  54. SAETANG J, Sangkhathat S
    Diets link metabolic syndrome and colorectal cancer development (Review).
    Oncol Rep. 2017 Jan 18. doi: 10.3892/or.2017.5385.
    PubMed     Text format     Abstract available


  55. CHEN Y, Zhang Y, He J, Fu Y, et al
    MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
    Oncol Rep. 2017 Jan 16. doi: 10.3892/or.2017.5371.
    PubMed     Text format     Abstract available


  56. WANG H, Chen Z, Chang H, Mu X, et al
    Expression of glia maturation factor gamma is associated with colorectal cancer metastasis and its downregulation suppresses colorectal cancer cell migration and invasion in vitro.
    Oncol Rep. 2017 Jan 9. doi: 10.3892/or.2017.5361.
    PubMed     Text format     Abstract available


  57. JANOWSKI E, Timofeeva O, Chasovskikh S, Goldberg M, et al
    Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.
    Oncol Rep. 2017;37:57-65.
    PubMed     Text format     Abstract available


  58. HUANG G, Chen X, Cai Y, Wang X, et al
    miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer.
    Oncol Rep. 2017;37:571-578.
    PubMed     Text format     Abstract available


    December 2016
  59. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Text format     Abstract available


  60. WANG T, Ning K, Lu TX, Hua D, et al
    Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5322.
    PubMed     Text format     Abstract available


  61. ZHANG C, Gong P, Liu P, Zhou N, et al
    Thioridazine elicits potent antitumor effects in colorectal cancer stem cells.
    Oncol Rep. 2016 Dec 14. doi: 10.3892/or.2016.5313.
    PubMed     Text format     Abstract available


    November 2016
  62. KIJIMA T, Hazama S, Tsunedomi R, Tanaka H, et al
    MicroRNA-6826 and -6875 in plasma are valuable noninvasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5267.
    PubMed     Text format     Abstract available


  63. MIYO M, Konno M, Colvin H, Nishida N, et al
    The importance of mitochondrial folate enzymes in human colorectal cancer.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5264.
    PubMed     Text format     Abstract available


  64. FU Q, Cheng J, Zhang J, Zhang Y, et al
    miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.
    Oncol Rep. 2016 Nov 18. doi: 10.3892/or.2016.5259.
    PubMed     Text format     Abstract available


  65. JIANG D, Wang L, Zhao T, Zhang Z, et al
    Restoration of the tumor-suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in colorectal cancer cells.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5246.
    PubMed     Text format     Abstract available


  66. WEN W, Liu G, Jin K, Hu X, et al
    TGF-beta1 induces PGP9.5 expression in CAFs to promote the growth of colorectal cancer cells.
    Oncol Rep. 2016 Nov 9. doi: 10.3892/or.2016.5238.
    PubMed     Text format     Abstract available


  67. ZHAO M, Yu Z, Li Z, Tang J, et al
    Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5231.
    PubMed     Text format     Abstract available


  68. LIU N, Li J, Zhao Z, Han J, et al
    MicroRNA-302a enhances 5-fluorouracil-induced cell death in human colon cancer cells.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5237.
    PubMed     Text format     Abstract available


  69. ONOZAWA H, Saito M, Saito K, Kanke Y, et al
    Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5234.
    PubMed     Text format     Abstract available


  70. ZHAO J, Lv Y, Cai Y, Wei W, et al
    Hyperthermic carbon dioxide pneumoperitoneum reinforces the inhibition of 5-FU on the proliferation and invasion of colon cancer.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5229.
    PubMed     Text format     Abstract available


  71. HUANG HL, Chen WC, Hsu HP, Cho CY, et al
    Silencing of argininosuccinate lyase inhibits colorectal cancer formation.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5221.
    PubMed     Text format     Abstract available


  72. KIM DH, Kim MJ, Sung B, Suh H, et al
    Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5219.
    PubMed     Text format     Abstract available


  73. LEE CY, Hsieh SL, Hsieh S, Tsai CC, et al
    Inhibition of human colorectal cancer metastasis by notoginsenoside R1, an important compound from Panax notoginseng.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5222.
    PubMed     Text format     Abstract available


  74. GAO L, Zhou Y, Zhou SX, Yu XJ, et al
    PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells.
    Oncol Rep. 2016 Nov 3. doi: 10.3892/or.2016.5216.
    PubMed     Text format     Abstract available


  75. WANG C, Guo D, Wang Q, You S, et al
    Aliskiren targets multiple systems to alleviate cancer cachexia.
    Oncol Rep. 2016;36:3014-3022.
    PubMed     Text format     Abstract available


  76. ZHOU X, Xing X, Zhang S, Liu L, et al
    Glucose-regulated protein 78 contributes to the proliferation and tumorigenesis of human colorectal carcinoma via AKT and ERK pathways.
    Oncol Rep. 2016;36:2723-2730.
    PubMed     Text format     Abstract available


  77. YASSIN S, Hu J, Xu H, Li C, et al
    In vitro and in vivo activities of an antitumor peptide HM-3: A special dose-efficacy relationship on an HCT116 xenograft model in nude mice.
    Oncol Rep. 2016;36:2951-2959.
    PubMed     Text format     Abstract available


  78. LAGERSTEDT-ROBINSON K, Rohlin A, Aravidis C, Melin B, et al
    Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Oncol Rep. 2016;36:2823-2835.
    PubMed     Text format     Abstract available


    October 2016
  79. SUZUKI N, Nakagawa F, Matsuoka K, Takechi T, et al
    Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5208.
    PubMed     Text format     Abstract available


  80. WU H, Cheng X, Ji X, He Y, et al
    Cortactin contributes to the tumorigenicity of colorectal cancer by promoting cell proliferation.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5207.
    PubMed     Text format     Abstract available


  81. RIFFO-CAMPOS AL, Castillo J, Vallet-Sanchez A, Ayala G, et al
    In silico RNA-seq and experimental analyses reveal the differential expression and splicing of EPDR1 and ZNF518B genes in relation to KRAS mutations in colorectal cancer cells.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5210.
    PubMed     Text format     Abstract available


  82. TAKATSUNA M, Morohashi S, Yoshizawa T, Hirai H, et al
    Myofibroblast distribution is associated with invasive growth types of colorectal cancer.
    Oncol Rep. 2016 Oct 25. doi: 10.3892/or.2016.5202.
    PubMed     Text format     Abstract available


  83. FU Q, Cheng J, Zhang J, Zhang Y, et al
    Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5195.
    PubMed     Text format     Abstract available


  84. WANG L, Yu P
    miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5193.
    PubMed     Text format     Abstract available


  85. ZHANG Y, Yuan J, Zhang X, Yan F, et al
    Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5194.
    PubMed     Text format     Abstract available


  86. LIN J, Feng J, Jin Y, Yan Z, et al
    Pien Tze Huang suppresses VEGF-C-mediated lymphangiogenesis in colorectal cancer.
    Oncol Rep. 2016 Oct 20. doi: 10.3892/or.2016.5186.
    PubMed     Text format     Abstract available


  87. MARLICZ W, Sielatycka K, Serwin K, Kubis E, et al
    Effect of colorectal cancer on the number of normal stem cells circulating in peripheral blood.
    Oncol Rep. 2016 Oct 18. doi: 10.3892/or.2016.5179.
    PubMed     Text format     Abstract available


  88. ZHOU X, Wang P, Zhang YJ, Xu JJ, et al
    Comparative proteomic analysis of melanosis coli with colon cancer.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5178.
    PubMed     Text format     Abstract available


  89. YI W, Xiao E, Ding R, Luo P, et al
    High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-kappaB/p53-apoptosis signaling pathway in colorectal cancer.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5177.
    PubMed     Text format     Abstract available


  90. ZHANG H, Qiao L, Li X, Wan Y, et al
    Tissue metabolic profiling of lymph node metastasis of colorectal cancer assessed by 1H NMR.
    Oncol Rep. 2016 Oct 14. doi: 10.3892/or.2016.5175.
    PubMed     Text format     Abstract available


  91. CHEN F, Sun G, Peng J
    RNAi-mediated HOXD3 knockdown inhibits growth in human RKO cells.
    Oncol Rep. 2016;36:1793-8.
    PubMed     Text format     Abstract available


  92. TIAN X, Yan L, Zhang D, Guan X, et al
    PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance.
    Oncol Rep. 2016;36:1829-36.
    PubMed     Text format     Abstract available


    September 2016
  93. FAN XJ, Wang Y, Wang L, Zhu M, et al
    Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway.
    Oncol Rep. 2016 Sep 30. doi: 10.3892/or.2016.5138.
    PubMed     Text format     Abstract available


  94. HOLZNER S, Senfter D, Stadler S, Staribacher A, et al
    Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro.
    Oncol Rep. 2016 Sep 20. doi: 10.3892/or.2016.5114.
    PubMed     Text format     Abstract available


  95. HUANG C, Liu H, Gong XL, Wu L, et al
    Expression of DNA methyltransferases and target microRNAs in human tissue samples related to sporadic colorectal cancer.
    Oncol Rep. 2016 Sep 19. doi: 10.3892/or.2016.5104.
    PubMed     Text format     Abstract available


  96. YOO HI, Kim BK, Yoon SK
    MicroRNA-330-5p negatively regulates ITGA5 expression in human colorectal cancer.
    Oncol Rep. 2016 Sep 15. doi: 10.3892/or.2016.5092.
    PubMed     Text format     Abstract available


  97. KIM BR, Kang MH, Kim JL, Na YJ, et al
    RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.
    Oncol Rep. 2016 Sep 12. doi: 10.3892/or.2016.5086.
    PubMed     Text format     Abstract available


    August 2016
  98. JING X, Wu H, Ji X, Wu H, et al
    Cortactin promotes cell migration and invasion through upregulation of the dedicator of cytokinesis 1 expression in human colorectal cancer.
    Oncol Rep. 2016 Aug 31. doi: 10.3892/or.2016.5058.
    PubMed     Text format     Abstract available


  99. LI S, Wu X, Xu Y, Wu S, et al
    miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5042.
    PubMed     Text format     Abstract available


  100. WU Y, Xie R, Liu X, Wang J, et al
    Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5041.
    PubMed     Text format     Abstract available


  101. ZHANG SS, Huang ZW, Li LX, Fu JJ, et al
    Identification of CD200+ colorectal cancer stem cells and their gene expression profile.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5039.
    PubMed     Text format     Abstract available


  102. RUWAN KUMARA MH, Piao MJ, Kang KA, Ryu YS, et al
    Non-thermal gas plasma-induced endoplasmic reticulum stress mediates apoptosis in human colon cancer cells.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5038.
    PubMed     Text format     Abstract available


  103. ACQUAVIVA R, Sorrenti V, Santangelo R, Cardile V, et al
    Effects of an extract of Celtis aetnensis (Tornab.) Strobl twigs on human colon cancer cell cultures.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5035.
    PubMed     Text format     Abstract available


  104. XIONG W, Gao D, Li Y, Liu X, et al
    Genome-wide profiling of chemoradiationinduced changes in alternative splicing in colon cancer cells.
    Oncol Rep. 2016 Aug 12. doi: 10.3892/or.2016.5022.
    PubMed     Text format     Abstract available


  105. OKADA K, Hakata S, Terashima J, Gamou T, et al
    Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
    Oncol Rep. 2016 Aug 8. doi: 10.3892/or.2016.5008.
    PubMed     Text format     Abstract available


    July 2016
  106. XU K, Wang J, Gao J, Di J, et al
    GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer.
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4961.
    PubMed     Text format     Abstract available


  107. XU W, Xu B, Yao Y, Yu X, et al
    RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4941.
    PubMed     Text format     Abstract available


  108. WEI H, Cheng Z, Ouyang C, Zhang Y, et al
    Glycoprotein screening in colorectal cancer based on differentially expressed Tn antigen.
    Oncol Rep. 2016 Jul 14. doi: 10.3892/or.2016.4937.
    PubMed     Text format     Abstract available


  109. TAKATSUNA M, Morohashi S, Yoshizawa T, Hirai H, et al
    Myofibroblasts of the muscle layer stimulate the malignant potential of colorectal cancer.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4932.
    PubMed     Text format     Abstract available


  110. ZHU L, Tian G, Yang Q, De G, et al
    Thyroid hormone receptor beta1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4931.
    PubMed     Text format     Abstract available


  111. LIANG L, Huang J
    Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-kappaB signaling in colorectal cancer cells.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4927.
    PubMed     Text format     Abstract available


  112. SUN ZZ, Zhang T, Ning K, Zhu R, et al
    B7-H3 upregulates BRCC3 expression, antagonizing DNA damage caused by 5-Fu.
    Oncol Rep. 2016;36:231-8.
    PubMed     Text format     Abstract available


  113. ZHANG Y, Lin L, Jin Y, Lin Y, et al
    Overexpression of WNT5B promotes COLO 205 cell migration and invasion through the JNK signaling pathway.
    Oncol Rep. 2016;36:23-30.
    PubMed     Text format     Abstract available


    June 2016
  114. IWAI T, Sugimoto M, Harada S, Yorozu K, et al
    Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.
    Oncol Rep. 2016 Jun 22. doi: 10.3892/or.2016.4902.
    PubMed     Text format     Abstract available


  115. KIM EH, Lee H, Jeong YK, Jung WG, et al
    Mechanisms of SU5416, an inhibitor of vascular endothelial growth factor receptor, as a radiosensitizer for colon cancer cells.
    Oncol Rep. 2016 Jun 10. doi: 10.3892/or.2016.4868.
    PubMed     Text format     Abstract available


  116. LIU J, Li Q, Liu Z, Lin L, et al
    Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the Akt and ERK signaling pathways.
    Oncol Rep. 2016;35:3363-70.
    PubMed     Text format     Abstract available


    May 2016
  117. KANG HR, Choi HG, Jeon CK, Lim SJ, et al
    Butyrate-mediated acquisition of chemoresistance by human colon cancer cells.
    Oncol Rep. 2016 May 27. doi: 10.3892/or.2016.4838.
    PubMed     Text format     Abstract available


  118. CUI F, Wang S, Lao I, Zhou C, et al
    miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
    Oncol Rep. 2016 May 24. doi: 10.3892/or.2016.4834.
    PubMed     Text format     Abstract available


  119. LEE MH, Hong SH, Park C, Kim GY, et al
    Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
    Oncol Rep. 2016 May 17. doi: 10.3892/or.2016.4812.
    PubMed     Text format     Abstract available


  120. HAN J, Liu Z, Wang N, Pan W, et al
    MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein.
    Oncol Rep. 2016 May 16. doi: 10.3892/or.2016.4810.
    PubMed     Text format     Abstract available


  121. ZHA H, Sun H, Li X, Duan L, et al
    S100A8 facilitates the migration of colorectal cancer cells through regulating macrophages in the inflammatory microenvironment.
    Oncol Rep. 2016 May 6. doi: 10.3892/or.2016.4790.
    PubMed     Text format     Abstract available


  122. SHOJI H, Motegi M, Osawa K, Okonogi N, et al
    Radiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer.
    Oncol Rep. 2016;35:2569-75.
    PubMed     Text format     Abstract available


    April 2016
  123. PONNUSAMY S, Lattmann E, Lattmann P, Thiyagarajan T, et al
    Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action.
    Oncol Rep. 2016;35:2097-106.
    PubMed     Text format     Abstract available


    March 2016
  124. KIM A, Im M, Ma JY
    Sosihotang ameliorates cachexiarelated symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss.
    Oncol Rep. 2016;35:1841-50.
    PubMed     Text format     Abstract available


    February 2016
  125. YORIFUJI N, Inoue T, Iguchi M, Fujiwara K, et al
    The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice.
    Oncol Rep. 2016;35:676-82.
    PubMed     Text format     Abstract available


    January 2016
  126. KASAI C, Sugimoto K, Moritani I, Tanaka J, et al
    Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
    Oncol Rep. 2016;35:325-33.
    PubMed     Text format     Abstract available


  127. WENG WH, Leung WH, Pang YJ, Hsu HH, et al
    Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression.
    Oncol Rep. 2016;35:107-16.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: